March 2024
ENT Devices Market (By Product: Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, and Nasal Splints; By End User: Hospitals, Clinics, Ambulatory Settings, & others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global ENT devices market was valued at USD 24.51 billion in 2023 and is expected to hit USD 37.2 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 4.74% during the forecast period 2023 to 2032.
The U.S. ENT devices market size was valued at USD 6.15 billion in 2023 and is expected to reach USD 9.38 billion by 2032, growing at a CAGR of 4.8% from 2023 to 2032.
Based on region, North America dominated the global ENT Devices market in 2022, in terms of revenue share of 36% and is estimated to sustain its dominance during the forecast period. Presence of developed healthcare infrastructure, increased health consciousness, rising healthcare expenditure, and rapidly surging popularity of the minimal invasive surgeries are the several crucial factors that spur the demand for the ENT devices in North America.
On the Other hand, Asia Pacific is expected to be the fastest-growing market during the forecast period. The growing prevalence of ear, nose, and throat related disorders among the old age population is fueling the demand for the ENT devices. According to the World Health Organization, the proportion of the global population of over 60 years is anticipated to double from 12% to 22%, between 2015 and 2050. Around 80% of the global geriatric population will be living in low and middle-income nations. Hence, Asia Pacific is estimated to be the fastest-growing market in the forthcoming years.
Report Highlights | Details |
Market Size in 2023 | USD 24.51Billion |
Market Size by 2032 | USD 37.2 Billion |
Growth Rate from 2023 to 2032 | CAGR of 4.74% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Product, End User, Region |
Companies Mentioned | Demant A/S, Sonova, Ambu A/S, Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf Gmbh, Widex, Cochlear Ltd., Sivantos, Inc. |
Based on product, the diagnostic ENT devices segment dominated the market 31% in 2022, in terms of revenue and is expected to sustain its dominance during the forecast period. This is attributable to the introduction of new technologies and availability of several products in the market.
The hearing aids segment is expected to grow at the noteworthy CAGR during the forecast period due to an increase in investment on R&D by market players.
Based on end user, the hospitals segment dominated the global ENT Devices market in 2022, in terms of revenue and is estimated to sustain its dominance during the forecast period. The factors augment the growth of the segment are increasing demand for hearing care devices and presence of large hospitals chains.
The clinics segment is expected to be the fastest-growing segment during the forecast period. This is attributed to the advancements in clinical diagnostic methods and increasing awareness about diagnosis and treatment of the disease.
Key Companies & Market Share Insights
Segments Covered in the Report
By Product
By End User
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
March 2024
September 2024
October 2024
January 2022